We deliver actionable, objective business and technology insights. Our expert guidance and tools enable faster, smarter decisions and stronger performance on an organization’s mission-critical priorities.
Our unrivaled combination of business and technology insights steers clients toward the right decisions on the issues that matter most. As a $6.5 billion company, with over 20,000 associates, and a member of the S&P 500, we are an objective partner with 13,000+ client enterprises in ~90 countries and territories — across every major function, geography, industry and market sector — and boast 45+ years of experience providing insights and expert guidance to client enterprises worldwide.
To learn more about how we guide the leaders who shape the world, visit gartner.com.
Gartner, Inc. (NYSE: IT)
Community guidelines: https://gtnr.it/3tceMrU
Hot Topics Across the C-Suite LinkedIn Newsletter: https://gtnr.it/4c56S97
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.
Be Part of Progress - together we bring greater understanding to the world
Springer Nature is one of the leading publishers of research in the world. We publish the largest number of journals and books and are a pioneer in open research. Through our leading brands, trusted for more than 180 years, we provide technology-enabled products, platforms and services that help researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning. We are proud to be part of progress, working together with the communities we serve to share knowledge and bring greater understanding to the world.
Global key facts:
Established for over 180 years
Nearly 10,000 colleagues
200 offices in over 40 countries on all continents
World’s largest academic book publisher
Publisher of Nature, the world’s most influential journal
First company to publish more than 1 million Open Access articles
Key brands and imprints:
Springer Nature is home to some of the best-known names in research, health and educational publishing. Every day, around the globe, our brands reach millions of people.
Nature Portfolio
Springer
BMC
Discover
Palgrave Macmillan
Apress
Macmillan Education
Springer Health+
Springer Medizin
Research Square
J.B. Metzler
BSL Media & Learning
Adis